National all-cause mortality during the COVID-19 pandemic: a Danish registry-based study

被引:16
|
作者
Mills, Elisabeth Helen Anna [1 ]
Moller, Amalie Lykkemark [2 ]
Gnesin, Filip [2 ]
Zylyftari, Nertila [2 ]
Broccia, Marcella [2 ,3 ]
Jensen, Britta [4 ]
Schou, Morten [5 ]
Fosbol, Emil L. [6 ]
Kober, Lars [6 ]
Andersen, Mikkel Porsborg [2 ]
Phelps, Matthew [7 ]
Gerds, Thomas [8 ]
Torp-Pedersen, Christian [1 ,2 ,7 ]
机构
[1] Aalborg Univ Hosp, Dept Cardiol, Aalborg, Denmark
[2] Nordsjaellands Hosp, Dept Clin Res, Hillerod, Denmark
[3] Aalborg Univ Hosp, Dept Obstet & Gynaecol, Aalborg, Denmark
[4] Aalborg Univ, Dept Hlth Sci & Technol, Aalborg, Denmark
[5] Herlev Gentofte Hosp, Dept Cardiol, Copenhagen, Denmark
[6] Rigshosp, Dept Cardiol, Copenhagen, Denmark
[7] Nordsjaellands Hosp, Dept Cardiol, Hillerod, Denmark
[8] Univ Copenhagen, Dept Biostat, Copenhagen, Denmark
关键词
Mortality; Covid-19; Comorbidity; Epidemiology; Population;
D O I
10.1007/s10654-020-00680-x
中图分类号
R1 [预防医学、卫生学];
学科分类号
1004 ; 120402 ;
摘要
Denmark implemented early widespread social distancing to reduce pressure on the healthcare system from the coronavirus disease 2019 (COVID-19) pandemic, with the aims to reduce mortality. Unintended consequences might be delays in treatment for other diseases and subsequent mortality. We examined national all-cause mortality comparing weeks 1-27 in 2020 and 2015-2019. This registry-based study used Danish national registry data until 5 July 2020. We examined all-cause mortality rates among all deaths recorded from 2015 to 2020 and among chronic conditions (cardiovascular (cardiac & circulatory), chronic pulmonary, chronic kidney disease, cancer, and diabetes), comparing each week in 2020 to weeks in 2015-2019. In 2020, there were 28,363 deaths in weeks 1-27 (30 December 2019-5 July 2020), the mean deaths in 2015-2019 were 28,630 deaths (standard deviation 784). Compared to previous years, the mortality rate in weeks 3-10 of 2020 was low, peaking in week 14 (17.6 per 100,000 persons in week 9, 19.9 per 100,000 in week 14). Comorbidity prevalence among deceased individuals was similar in 2020 and 2015-2019: 71.1% of all deceased had a prior cardiovascular diagnosis, 30.0% of all deceased had a prior cardiac diagnosis. There were 493 deaths with COVID-19 in weeks 11-27, (59.8% male), and 75.1% had a prior cardiovascular diagnosis. Weekly mortality rates for pre-existing chronic conditions peaked in week 14, and then declined. During the COVID-19 pandemic, due to timely lockdown measures, the mortality rate in Denmark has not increased compared to the mortality rates in the same period during 2015-2019.
引用
收藏
页码:1007 / 1019
页数:13
相关论文
共 50 条
  • [41] Variation in excess all-cause mortality by age, sex, and province during the first wave of the COVID-19 pandemic in Italy
    Nathaniel J. Henry
    Ahmed Elagali
    Michele Nguyen
    Michael Give Chipeta
    Catrin E. Moore
    [J]. Scientific Reports, 12
  • [42] Variation in excess all-cause mortality by age, sex, and province during the first wave of the COVID-19 pandemic in Italy
    Henry, Nathaniel J.
    Elagali, Ahmed
    Nguyen, Michele
    Chipeta, Michael Give
    Moore, Catrin E.
    [J]. SCIENTIFIC REPORTS, 2022, 12 (01)
  • [43] Impact of heart failure on all-cause mortality in COVID-19: findings from the Eurasian International Registry
    Arutyunov, Gregory P.
    Tarlovskaya, Ekaterina I.
    Arutyunov, Alexander G.
    Lopatin, Yury M.
    [J]. ESC HEART FAILURE, 2023, 10 (02): : 1013 - 1024
  • [44] Excess mortality in adults from Sao Paulo during the COVID-19 pandemic in 2020: analyses of all-cause and noncommunicable diseases mortality
    Resende, Bruna de Souza
    Dias, Rayara Mozer
    Ferrari, Gerson
    Rezende, Leandro F. M.
    [J]. SCIENTIFIC REPORTS, 2023, 13 (01)
  • [45] Excess mortality in adults from Sao Paulo during the COVID-19 pandemic in 2020: analyses of all-cause and noncommunicable diseases mortality
    Bruna de Souza Resende
    Rayara Mozer Dias
    Gerson Ferrari
    Leandro F. M. Rezende
    [J]. Scientific Reports, 13
  • [46] Impact of Metabolic Acidosis on All-Cause Mortality in Patients With COVID-19
    Kim, Yaerim
    Kwon, Soie
    Lee, Jeonghwan
    Paek, Jin Hyuk
    Park, Woo Yeong
    Jin, Kyubok
    Han, Seungyeup
    Kim, Dong Ki
    Lee, Jung Pyo
    [J]. JOURNAL OF THE AMERICAN SOCIETY OF NEPHROLOGY, 2022, 33 (11): : 332 - 333
  • [47] In COVID-19, tocilizumab reduces all-cause mortality at 28 d
    Fernando, Shannon M.
    Rochwerg, Bram
    [J]. ANNALS OF INTERNAL MEDICINE, 2021, 174 (06) : JC63 - JC63
  • [48] Predictors of All-Cause Mortality in Heart Transplant Recipients With COVID-19
    De Sirkar, Sovik
    Yu, Mingxi
    [J]. CIRCULATION, 2021, 144
  • [49] Anticoagulants and all-cause mortality among hospitalized COVID-19 patients
    Liang, Caihua
    Zhou, Li
    Doherty, Michael C.
    Gately, Robert V.
    Ogilvie, Rachel P.
    Chomistek, Andrea K.
    Wang, Florence
    Seeger, John D.
    Franklin, Jessica
    [J]. PHARMACOEPIDEMIOLOGY AND DRUG SAFETY, 2021, 30 : 78 - 78
  • [50] IS TRANSAMINITIS AN INDEPENDENT RISK FACTOR FOR ALL-CAUSE MORTALITY IN COVID-19?
    Mughal, Mohsin
    Kaur, Ikwinder P.
    Kakadia, Mili
    Alhashemi, Reem
    Qudah, Hamzah A.
    Azad, Sarah
    Wang, Chang
    Mirza, Hasan M.
    Singh, Harjot
    Priya, Angi
    Eng, Margaret
    [J]. GASTROENTEROLOGY, 2021, 160 (06) : S851 - S851